Myricitrin
Specifications
17912-87-7CAS Number
241-856-7EC Number
5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-oneIUPAC Name
C21H20O12Chemical Formula
464.4 g/molMolecular Weight
Myricitrin; 17912-87-7; Myricitroside; Myricitrine; Myricetin 3-O-rhamnoside; Myricetin 3-O-alpha-L-rhamnopyranoside; 5Z0ZO61WPJ; DTXSID40170771; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; FEMA NO. 4491; CHEBI:70082; NSC-19803; 5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside; 5,7-dihydroxy-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; RefChem:160395; 3,3',4',5,5',7-Hexahydroxyflavone 3-Rhamnoside; DTXCID5093262; 241-856-7; Myricetrin; Myricetol 3-rhamnoside; MFCD00016930; Myricetin 3-O-alpha-L-rhamnoside; MLS000574998; NSC19803; 5,7-dihydroxy-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one; SMR000232363; 3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-benzopyran-4-one; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; 3,3',4',5,5',7-Hexahydroxyflavone, 3-rhamnoside; 4H-1-Benzopyran-4-one, 3-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-; Flavone,3,3',4',5,5',7-hexahydroxy-,3-rhamnoside; UNII-5Z0ZO61WPJ; Myricetin-3-O-alpha-L-rhamnoside; myricetin-rhamnoside; Myricitrin (7); 4H-1-BENZOPYRAN-4-ONE, 3-((6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)OXY)-5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-; Myricetin 3-O-.alpha.-L-rhamnopyranoside; EINECS 241-856-7; NSC 19803; Myricitrin (Standard); myricetin-3-rhamnoside; Myricitrin (Myricitrine); 5,7-Dihydroxy-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-(3,4,5-trihydroxy-phenyl)-1-benzopyran-4-one; SCHEMBL226022; Myricitrin, analytical standard; CHEMBL522983; MEGxp0_000257; orb1305064; orb3140812; SCHEMBL30637444; ACon1_000103; BDBM34753; cid_5281673; HY-N0152R; BDBM153266; HMS2218N08; HY-N0152; Myricitrin, >=99.0% (HPLC); AC-638; LMPK12112436; MYRICETIN 3-O-RHAMNOPYRANOSIDE; AKOS015896842; CCG-208406; EBC-465054; MM08117; NCGC00163596-01; NCGC00163596-02; NCGC00163596-06; 3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one; 5,7-dihydroxy-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one; BS-16289; SY073681; CS-0007883; NS00021765; S2327; MYRICETIN 3-O-.ALPHA.-L-RHAMNPYRONOSIDE; F795244; SR-01000712005; Myricitrin, primary pharmaceutical reference standard; Q6948223; SR-01000712005-3; 3-[(2S,3R,4R,5R,6S)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)-2-[3,4,5-tris(oxidanyl)phenyl]chromen-4-one; 3-[(6-deoxy-a-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-benzopyran-4-one; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromone; 5,7-dihydroxy-3-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxy]-2-(3,4,5-trihydroxyphenyl)-1-benzopyran-4-one; 5,7-Dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-3-yl 6-deoxy-alpha-L-mannopyranosideSynonyms
